Avidity Partners Management LP 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:19 pm Sale |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Avidity Partners Management LP | 0 0.000% |
-1,278,261 (Position Closed) |
Filing |
| 2022-02-11 8:10 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Avidity Partners Management LP | 1,278,261 5.900% |
1,278,261 (New Position) |
Filing |
| 2021-10-27 6:12 pm Purchase |
2021-10-21 | 13G | Viridian Therapeutics, Inc. VRDN |
Avidity Partners Management LP | 1,120,925 6.600% |
1,120,925 (New Position) |
Filing |